In its comprehensive study, ONS stated: During the week of April 11 in the UK, 68.3 per cent of the 56 million adults in the UK, the most populous country in the UK, were diagnosed with the SARS-CoV-2 corona virus infection or vaccine, according to a representative census. The presence of antibodies In the case of screening by blood test.
According to the Statistics Office In Wales, the proportion of adults is 61 per cent, in Scotland 57.8 per cent, in Northern Ireland 62.5 per cent. The new type of corona virus may have antibodies.
A similar statistical study conducted earlier this year suggested that at that time, about ten percent of the adult population could be tested for antibodies to the corona virus.
A new study by the Statistics Office, released Wednesday, indicates that The vaccine campaign in the UK plays a key role in the significant increase in antibody production.
According to an ONS survey, the elderly population in the UK has the highest number of people with antibodies to the corona virus, and the UK vaccination campaign, which began on December 8, has recently focused on the elderly and the most vulnerable.
According to the study, the proportion of 16-49 year olds in the week ending April 11 ranged from 46.5 to 54.3 per cent and that of 70-74 year olds 87.6 per cent.
The British government had already announced two weeks ago that members over the age of 50 and all most vulnerable groups in the UK had received the first dose of the corona virus vaccine by the April 15 deadline and two days before the UK Public Health Service. This week the NHS in the UK) opened the opportunity to book vaccination dates before the age of 42.
According to the latest UK-wide data from the UK Health Department, 33,843,580 people have so far received the first dose of the corona virus vaccine.
This means that 64.5 percent of British adults have been vaccinated for the first time.
According to a comprehensive study conducted by the English Public Health Service (PHE) on Wednesday, there are two main types of vaccines used in the UK: Pfizer / Bioentech and Oxford / Astrogeneneka. Even after the first dose, it reduced the risk of those who were vaccinated, despite the fact that the corona virus survives in the same way as those who live in the same home.
PHE experts emphasize the importance of the test result in that regard Vaccines have now been shown to significantly reduce the risk of serious illness and death and to reduce the spread of the corona virus, even from people living close to each other.
Another large study by the UK Bureau of Statistics and the University of Oxford, comprising 372,000 people, shows that those vaccinated with the first dose of Oxford / Astrogeneneka and Pfizer / Bioendech in early December and early April have an average of 65 chances. Corona virus infection was reduced by one percent.
Cover Image Source: Getty Images